As Chair of the Board Nominating Committee, I am asking for your help to identify colleagues within ISPE who would be well-suited to serve on the ISPE International Board of Directors. The International Board of Directors is responsible for the governance and strategic direction of our Society. Members of the Board are people who know our Society, understand our industry and have strong strategic leadership capabilities. Potential candidates should have most, if not all, of the following characteristics:
In an effort to represent a global view of our industry and to ensure organizational success, it is important we have an appropriately diverse International Board of Directors. Diversity is represented in many ways; examples may include business expertise, gender, geographic location and young professionals. If you know of someone who fits the above description and can expand our Board diversity, I encourage you to reach out to them, confirm their willingness to be considered, and send a completed Nomination Form along with the nominee's curriculum vitae or resume to nominations@ispe.org by 14 April 2017. Self-nominations are also welcome. Thank you for your help with this critical task for ISPE.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...